|
KMID : 0338420140290050577
|
|
The Korean Journal of Internal Medicine
2014 Volume.29 No. 5 p.577 ~ p.579
|
|
|
Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
|
|
Kwok Seung-Ki
|
|
|
Abstract
|
|
|
|
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|